Open AccessCardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal Dialysis
Author(s) -
Botond Csiky,
Balázs Sági,
Vanessza Emmert,
István Wittmann,
Endre Sulyok
Publication year - 2021
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000517529
Subject(s) - peritoneal dialysis , end stage renal disease , medicine , dialysis , disease , kidney disease , intensive care medicine , urology , endocrinology , gastroenterology
Data on the role of irisin in vascular calcification in patients with end-stage renal diseases on regular dialysis are inconsistent, and the underlying mechanisms are not clearly defined. The present study was designed to explore the association of serum irisin with vascular stiffness and with the impact of well-established risk factors.